REFRACTORY SOLID TUMOR
Clinical trials for REFRACTORY SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMOR trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for kids with rare cancers
Disease control Recruiting nowThis study tests a combination of four drugs (cyclophosphamide, sorafenib, bevacizumab, and atezolizumab) in children and young adults with solid tumors that have come back or not responded to treatment. The goal is to find safe doses and see if the drugs shrink tumors. The trial…
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill takes on Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called CID-078 in 220 adults with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink tumors. It is a first-in-human trial, so the main focus is on …
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1 • Sponsor: Circle Pharma • Aim: Disease control
Last updated May 11, 2026 20:49 UTC